GUANGZHOU IMPROVE MEDICAL INSTRUMENTS CO., LTD - Manufacturer Profile
Explore comprehensive manufacturer profile for GUANGZHOU IMPROVE MEDICAL INSTRUMENTS CO., LTD through Pure Global AI's free Ecuador medical device database. This company manufactures 17 medical devices registered with ARCSA across 1 risk class. Their registration history spans from Nov 17, 2023 to Nov 17, 2023.
Free Manufacturer Profile
Powered by Pure Global AI
17 Devices
GUANGZHOU IMPROVE MEDICAL INSTRUMENTS CO., LTD
Manufacturer
17
Total Devices
1
Risk Classes
2023
Earliest
2023
Latest
Recent Registrations
Latest 10 ARCSA device registrations
Evacuated Blood Collection Tube / Sodium Heparin Tube (13x75 mm; 13x100 mm; 16x100 mm)
114e07696f0cbbb4518fa5aff0a91201
I
Nov 17, 2023
Evacuated Blood Collection Tube / No Additive Tube (13x75 mm; 13x100 mm; 16x100 mm)
41900a60f07f1a96ab743f8418b49363
I
Nov 17, 2023
Evacuated Blood Collection Tube / Clot Activator Tube (13x75 mm; 13x100 mm; 16x100 mm)
85406b75e6502ffe0197b34a1f5594e5
I
Nov 17, 2023
Evacuated Blood Collection Tube / Gel & Clot Activator Tube (13x75 mm; 13x100 mm; 16x100 mm)
55403ab7df00d32436128b550f7adaca
I
Nov 17, 2023
Evacuated Blood Collection Tube / EDTA. K2 Tube (13x75 mm; 13x100 mm; 16x100 mm)
6c76694a28455bd62f3ceaa999634243
I
Nov 17, 2023
Evacuated Blood Collection Tube / EDTA. K3 Tube (13x75 mm; 13x100 mm; 16x100 mm)
81a53b03c6357ec986a36e646a19b8ad
I
Nov 17, 2023
Evacuated Blood Collection Tube / Citrate Tube (9NC 0.109M/0.129M) (13x75 mm; 13x100 mm; 16x100 mm)
3fc1cff3ebedff8f496c32b3bee20f59
I
Nov 17, 2023
Evacuated Blood Collection Tube / ESR Tube (4NC 0.109M/0.129M) (13x75 mm; 13x100 mm; 8x120 mm; 9x120 mm)
a47d463fd3054753a711101b042e033c
I
Nov 17, 2023
Evacuated Blood Collection Tube / Lithium Heparin Tube (13x75 mm; 13x100 mm; 16x100 mm)
0690c2dd40af40ce912b70d45318694e
I
Nov 17, 2023
Evacuated Blood Collection Tube / Glucose Tube (Sodium Fluoride EDTA. Na2) (13x75 mm; 13x100 mm)
efca6abf5112ce1519add70863355643
I
Nov 17, 2023
Risk Class Distribution
Devices by risk class
I
17
100.0% of total

